Literature DB >> 29979032

Comparison of Copper(II)-Ligand Complexes as Mediators for Preparing Electrochemically Modulated Nitric Oxide-Releasing Catheters.

Kamila K Konopińska, Nicholas J Schmidt, Andrew P Hunt, Nicolai Lehnert, Jianfeng Wu, Chuanwu Xi, Mark E Meyerhoff.   

Abstract

Further studies aimed at examining the activity of different Cu(II)-ligand complexes to serve as electron-transfer mediators to prepare novel antimicrobial/thromboresistant nitric oxide (NO)-releasing intravenous catheters are reported. In these devices, the NO release can be modulated by applying different potentials or currents to reduce the Cu(II)-complexes to Cu(I) species which then reduce nitrite ions into NO(g) within a lumen of the catheter. Four different ligands are compared with respect to NO generation efficiency and stability over time using both single- and dual-lumen silicone rubber catheters: N-propanoate- N, N-bis(2-pyridylethyl)amine (BEPA-Pr), N-propanoate- N, N-bis(2-pyridylmethyl)amine (BMPA-Pr), 1,4,7-trimethyl-1,4,7-triazacyclononane (Me3TACN), and tris(2-pyridylmethyl)amine (TPMA). Of these, the Cu(II)BEPA-Pr and Cu(II)Me3TACN complexes provide biomedically useful NO fluxes from the surface of the catheters, >2 × 10-10 mol·min-1·cm-2, under conditions mimicking the bloodstream environment. Cu(II)Me3TACN exhibits the best stability over time with a steady and continuous NO release observed for 8 d under a nitrogen atmosphere. Antimicrobial experiments conducted over 5 d with NO-releasing catheters turned "on" electrochemically for only 3 or 6 h each day revealed >2 logarithmic units in reduction of bacterial biofilm attached to the catheter surfaces. The use of optimal Cu(II)-ligand complexes within a lumen reservoir along with high levels of nitrite ions can potentially provide an effective method of preventing/decreasing the rate of infections caused by intravascular catheters.

Entities:  

Keywords:  antimicrobial catheters; copper(II) complexes; electrochemical nitrite reduction; intravenous catheters; modulated NO-release; nitric oxide

Mesh:

Substances:

Year:  2018        PMID: 29979032      PMCID: PMC6215362          DOI: 10.1021/acsami.8b05917

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  32 in total

Review 1.  Guidelines for the management of intravascular catheter-related infections.

Authors:  L A Mermel; B M Farr; R J Sherertz; I I Raad; N O'Grady; J S Harris; D E Craven
Journal:  Clin Infect Dis       Date:  2001-04-03       Impact factor: 9.079

Review 2.  Nitric oxide insufficiency, platelet activation, and arterial thrombosis.

Authors:  J Loscalzo
Journal:  Circ Res       Date:  2001-04-27       Impact factor: 17.367

3.  Catheter lock heparin concentration: effects on tissue plasminogen activator use in tunneled cuffed catheters.

Authors:  Jean L Holley; Sandra Bailey
Journal:  Hemodial Int       Date:  2007-01       Impact factor: 1.812

Review 4.  The role of chelators in preventing biofilm formation and catheter-related bloodstream infections.

Authors:  Issam I Raad; Xiang Fang; Xavier M Keutgen; Ying Jiang; Robert Sherertz; Ray Hachem
Journal:  Curr Opin Infect Dis       Date:  2008-08       Impact factor: 4.915

5.  Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm.

Authors:  Steven L Percival; Peter Kite; Kerrie Eastwood; Ricardo Murga; Janice Carr; Matthew J Arduino; Rodney M Donlan
Journal:  Infect Control Hosp Epidemiol       Date:  2005-06       Impact factor: 3.254

Review 6.  Catheter dysfunction: the role of lock solutions.

Authors:  Vandana Dua Niyyar
Journal:  Semin Dial       Date:  2011-12-16       Impact factor: 3.455

7.  Eradication of microorganisms embedded in biofilm by an ethanol-based catheter lock solution.

Authors:  Damien Balestrino; Bertrand Souweine; Nicolas Charbonnel; Alexandre Lautrette; Claire Aumeran; Ousmane Traoré; Christiane Forestier
Journal:  Nephrol Dial Transplant       Date:  2009-04-21       Impact factor: 5.992

8.  Electrochemically modulated nitric oxide (NO) releasing biomedical devices via copper(II)-Tri(2-pyridylmethyl)amine mediated reduction of nitrite.

Authors:  Hang Ren; Jianfeng Wu; Chuanwu Xi; Nicolai Lehnert; Terry Major; Robert H Bartlett; Mark E Meyerhoff
Journal:  ACS Appl Mater Interfaces       Date:  2014-03-14       Impact factor: 9.229

9.  Efficient Eradication of Mature Pseudomonas aeruginosa Biofilm via Controlled Delivery of Nitric Oxide Combined with Antimicrobial Peptide and Antibiotics.

Authors:  Hang Ren; Jianfeng Wu; Alessandro Colletta; Mark E Meyerhoff; Chuanwu Xi
Journal:  Front Microbiol       Date:  2016-08-17       Impact factor: 5.640

10.  Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients.

Authors:  Arne Simon; Roland A Ammann; Gertrud Wiszniewsky; Udo Bode; Gudrun Fleischhack; Mette M Besuden
Journal:  BMC Infect Dis       Date:  2008-07-29       Impact factor: 3.090

View more
  3 in total

1.  Nitric Oxide Generation On Demand for Biomedical Applications via Electrocatalytic Nitrite Reduction by Copper BMPA- and BEPA-Carboxylate Complexes.

Authors:  Andrew P Hunt; Allison E Batka; Marjan Hosseinzadeh; Jordan D Gregory; Halima K Haque; Hang Ren; Mark E Meyerhoff; Nicolai Lehnert
Journal:  ACS Catal       Date:  2019-07-15       Impact factor: 13.084

2.  Endothelium-Mimicking Multifunctional Coating Modified Cardiovascular Stents via a Stepwise Metal-Catechol-(Amine) Surface Engineering Strategy.

Authors:  Ying Yang; Peng Gao; Juan Wang; Qiufen Tu; Long Bai; Kaiqin Xiong; Hua Qiu; Xin Zhao; Manfred F Maitz; Huaiyu Wang; Xiangyang Li; Qiang Zhao; Yin Xiao; Nan Huang; Zhilu Yang
Journal:  Research (Wash D C)       Date:  2020-04-24

3.  Polydopamine/poly(sulfobetaine methacrylate) Co-deposition coatings triggered by CuSO4/H2O2 on implants for improved surface hemocompatibility and antibacterial activity.

Authors:  Zhongqiang Zhu; Qiang Gao; Ziyue Long; Qiuyi Huo; Yifan Ge; Ntakirutimana Vianney; Nishimwe Anodine Daliko; Yongchun Meng; Jia Qu; Hao Chen; Bailiang Wang
Journal:  Bioact Mater       Date:  2021-02-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.